Free tool
Stocks listed on Stockholm
We cover 119 companies listed on Stockholm. The median market value in the group is $13.16M. Across the group, the median move over the past trading day is +0.45%. 35% of the 118 with a 200-day average trade above it. Price change over the past year runs from −79.8% to +25.4% across the middle 80 percent of the group, with a median of −33.6%.
Other lists in this group
Table
119 of 928 companies match these filters.Clear filters
| Ticker | Company | Price | 1M return | YTD return | 1Y return |
|---|---|---|---|---|---|
| GETI-B.ST | Getinge AB (publ) | 246.60 SEK | +4.45% | +16.11% | +21.94% |
| SECT-B.ST | Sectra AB (publ) | 295.40 SEK | +5.88% | +23.29% | −10.34% |
| MCOV-B.ST | Medicover AB (publ) | 246.00 SEK | +8.37% | +16.15% | −6.91% |
| CAMX.ST | Camurus AB (publ) | 608.00 SEK | −2.09% | −0.65% | −15.56% |
| BIOA-B.ST | BioArctic AB (publ) | 332.00 SEK | +2.79% | +7.45% | +10.37% |
| ASKER.ST | Asker Healthcare Group AB (publ) | 75.70 SEK | −6.95% | −7.52% | −20.70% |
| EKTA-B.ST | Elekta AB (publ) | 55.05 SEK | +12.95% | −0.93% | +22.79% |
| ALIF-B.ST | AddLife AB (publ) | 167.90 SEK | +3.32% | +11.90% | −4.16% |
| NANEXA.ST | Nanexa AB (publ) | 4.99 SEK | +18.95% | +23.98% | +119.34% |
| IBT-B.ST | Infant Bacterial Therapeutics AB (publ) | 67.90 SEK | +3.51% | +36.35% | +4.46% |
| ONCO.ST | Oncopeptides AB (publ) | 2.08 SEK | +31.19% | −57.37% | −58.44% |
| EQL.ST | EQL Pharma AB (publ) | 25.10 SEK | +21.55% | −57.60% | −69.35% |
| DICOT.ST | Dicot Pharma AB | 0.20 SEK | +8.28% | −36.06% | −77.37% |
| CINPHA.ST | Cinclus Pharma Holding AB (publ) | 14.00 SEK | +17.85% | −27.08% | −10.26% |
| BACTI-B.ST | Bactiguard Holding AB (publ) | 18.75 SEK | +19.05% | −1.32% | −30.04% |
| SEZI.ST | Senzime AB (publ) | 3.56 SEK | −3.92% | −34.41% | −45.48% |
| FLUO.ST | FluoGuide A/S | 33.20 SEK | +6.41% | −10.03% | −18.23% |
| EPIS-B.ST | Episurf Medical AB (publ) | 0.08 SEK | +32.26% | +87.71% | +64.00% |
| MOB.ST | Moberg Pharma AB (publ) | 10.54 SEK | +11.18% | +2.93% | +29.64% |
| XSPRAY.ST | Xspray Pharma AB (publ) | 10.24 SEK | −38.46% | −66.26% | −77.49% |
| CANTA.ST | Cantargia AB (publ) | 2.02 SEK | +11.12% | −51.02% | −26.48% |
| ORX.ST | Orexo AB (publ) | 13.78 SEK | −5.62% | −57.53% | −34.07% |
| IMMU.ST | Mendus AB (publ) | 7.00 SEK | +1.01% | +21.32% | −3.18% |
| CLBIO.ST | Corline Biomedical AB | 16.85 SEK | −5.07% | −2.60% | +30.12% |
| ENZY.ST | Enzymatica AB (publ) | 1.76 SEK | −6.88% | −8.33% | −26.67% |
| OSSD.ST | OssDsign AB (publ) | 3.73 SEK | −18.40% | −67.04% | −75.17% |
| MNTC.ST | Mentice AB (publ) | 13.55 SEK | −8.75% | +1.12% | −1.45% |
| ORT-B.ST | Ortoma AB (publ) | 7.80 SEK | +2.90% | −42.22% | −67.23% |
| IVACC.ST | Intervacc AB (publ) | 1.06 SEK | −17.42% | +14.32% | −10.00% |
| QLINEA.ST | Q-linea AB (publ) | 18.45 SEK | −0.27% | −36.38% | −62.67% |
| SPRINT.ST | Sprint Bioscience AB (publ) | 3.18 SEK | −14.75% | +113.42% | +457.89% |
| BIOWKS.ST | Bio-Works Technologies AB (publ) | 3.34 SEK | −8.49% | +15.57% | +3.41% |
| BRAIN.ST | BrainCool AB (publ) | 0.82 SEK | +9.53% | +36.23% | −15.00% |
| ACARIX.ST | Acarix AB (publ) | 0.25 SEK | −0.20% | −8.33% | −15.38% |
| ISOFOL.ST | Isofol Medical AB (publ) | 0.80 SEK | +2.19% | +6.57% | −5.81% |
| IRLAB-A.ST | IRLAB Therapeutics AB (publ) | 1.67 SEK | +28.26% | −16.92% | −45.42% |
| KLAR.ST | Klaria Pharma Holding AB (publ.) | 0.99 SEK | +20.93% | +41.14% | +87.83% |
| INTEG-B.ST | Integrum AB (publ) | 8.84 SEK | +5.24% | −15.00% | −79.13% |
| SCIB.ST | SciBase Holding AB (publ) | 20.00 SEK | −33.33% | −20.00% | −32.96% |
| XBRANE.ST | Xbrane Biopharma AB (publ) | 9.20 SEK | −10.68% | −11.32% | −74.53% |
| DEX.ST | Dextech Medical AB | 10.35 SEK | −2.82% | +11.89% | +19.65% |
| ELIC.ST | Elicera Therapeutics AB (publ) | 2.67 SEK | +16.34% | −48.46% | −62.23% |
| XINT.ST | Xintela AB (publ) | 0.19 SEK | −0.80% | −36.18% | −50.13% |
| ALZ.ST | Alzinova AB (publ) | 0.90 SEK | −11.91% | +6.55% | −30.08% |
| PRO.ST | Promimic AB (publ) | 9.00 SEK | −10.89% | −41.75% | −39.39% |
| ORTI-A.ST | Ortivus AB (publ) | 2.00 SEK | +6.38% | +52.67% | −35.48% |
| SENZA.ST | SenzaGen AB | 5.16 SEK | −1.90% | −14.00% | −15.96% |
| ABERA.ST | Abera Bioscience AB | 7.92 SEK | −5.71% | +10.00% | −0.38% |
| HEART.ST | Scandinavian Real Heart AB (Publ) | 19.15 SEK | −5.20% | +37.27% | +4.08% |
| INIT.ST | Initiator Pharma A/S | 2.35 SEK | +4.91% | −22.70% | −35.62% |
| DMYD-B.ST | Diamyd Medical AB (publ) | 1.02 SEK | −0.58% | −91.19% | −90.94% |
| ACUC.ST | AcuCort AB (publ) | 0.60 SEK | −7.38% | −5.94% | +4.70% |
| NICA.ST | Nanologica AB (publ) | 0.46 SEK | +0.22% | −38.93% | −67.40% |
| ORTI-B.ST | Ortivus AB (publ) | 1.64 SEK | −12.80% | +34.02% | +38.56% |
| IZAFE-B.ST | iZafe Group AB (publ) | 0.34 SEK | +0.90% | −26.70% | −1.47% |
| ACTI.ST | Active Biotech AB (publ) | 5.29 SEK | +2.12% | +15.00% | −63.57% |
| SIMRIS-B.ST | Simris Group AB (PUBL) | 0.10 SEK | −25.29% | +117.19% | −32.87% |
| NOSA.ST | Nosa Plugs AB | 0.51 SEK | +3.17% | −12.78% | −31.29% |
| PTRK.ST | Physitrack PLC | 7.96 SEK | −3.16% | −39.47% | −62.10% |
| BIOVIC-B.ST | Biovica International AB (publ) | 0.43 SEK | −16.60% | +0.23% | −35.52% |
| BOUL.ST | Boule Diagnostics AB (publ) | 3.20 SEK | −9.86% | −39.39% | −48.72% |
| NXTCL.ST | NextCell Pharma AB | 1.06 SEK | −4.32% | +51.57% | −9.06% |
| ARCOMA.ST | Arcoma AB | 8.10 SEK | −2.17% | +12.50% | −4.26% |
| ICO.ST | Iconovo AB (publ) | 1.21 SEK | +21.00% | +8.04% | −51.21% |
| VIVE.ST | Vivesto AB | 8.98 SEK | +3.82% | −20.39% | −56.92% |
| ONCOZ.ST | OncoZenge AB (publ) | 5.20 SEK | −23.53% | −21.09% | −23.08% |
| CMOTEC-B.ST | Scandinavian ChemoTech AB | 3.07 SEK | −6.40% | −33.41% | −14.72% |
| BIBB.ST | BiBBInstruments AB | 0.60 SEK | −12.87% | −83.63% | −84.80% |
| IMMNOV.ST | Immunovia AB (publ) | 0.14 SEK | −22.98% | −38.59% | −69.92% |
| ANNX.ST | Annexin Pharmaceuticals AB (publ) | 13.65 SEK | +5.00% | −31.41% | −45.40% |
| IDLDX.ST | IDL Diagnostics AB (publ) | 0.40 SEK | −0.49% | +16.76% | −4.49% |
| SPAGO.ST | Spago Nanomedical AB (publ) | 0.12 SEK | −2.53% | +5.00% | −56.74% |
| CLS-B.ST | Clinical Laserthermia Systems AB (publ) | 1.87 SEK | −1.69% | −72.52% | −77.84% |
| ACE.ST | Ascelia Pharma AB (publ) | 0.63 SEK | +22.94% | −80.68% | −87.31% |
| NEWBRY.ST | Newbury Pharmaceuticals AB (publ) | 2.52 SEK | −6.67% | +106.56% | −2.70% |
| PILA.ST | Pila Pharma AB (publ) | 1.49 SEK | +25.21% | −26.60% | −26.60% |
| PEXA-B.ST | PExA AB (publ) | 0.36 SEK | −26.58% | +56.09% | +69.34% |
| ACOU.ST | AcouSort AB (publ) | 3.49 SEK | +0.29% | +7.38% | +8.39% |
| SYNT.ST | SyntheticMR AB (publ) | 0.73 SEK | +20.33% | −45.02% | −73.79% |
| CHOSA.ST | Chosa Oncology AB | 0.72 SEK | −4.23% | −20.44% | −15.32% |
| ERMA.ST | Enorama Pharma AB (publ) | 0.90 SEK | +177.54% | −54.56% | −66.59% |
| MODTX.ST | Modus Therapeutics Holding AB (publ) | 0.45 SEK | +30.50% | +43.55% | −79.77% |
| NEOLA.ST | Neola Medical AB (publ) | 0.48 SEK | −20.66% | −55.35% | −79.22% |
| QLIFE.ST | Qlife Holding AB (publ) | 1.77 SEK | −8.97% | −32.34% | −54.72% |
| REDS.ST | Redsense Medical AB (publ) | 3.16 SEK | −20.60% | −26.34% | −36.80% |
| FLUI.ST | Fluicell AB (publ) | 38.70 SEK | +22.86% | +287.00% | +287.00% |
| SDOS.ST | ScandiDos AB (publ) | 0.88 SEK | +6.02% | −23.48% | −34.08% |
| ODI.ST | ODI Pharma AB (publ) | 2.68 SEK | +15.52% | −37.09% | +74.03% |
| SERV.ST | Servana AB | 0.01 SEK | −25.00% | +200.00% | +100.00% |
| KONT.ST | Kontigo Care AB (publ) | 1.30 SEK | −11.26% | −27.78% | −43.48% |
| BIOSGN.ST | Biosergen AB (publ) | 2.00 SEK | +204.37% | −95.00% | −95.53% |
| AINO.ST | Aino Health AB (publ) | 0.20 SEK | +2.06% | +3.66% | −18.85% |
| PMED.ST | PEPTONIC medical AB (publ) | 0.00 SEK | 0.00% | −25.00% | −14.29% |
| EXPRS2.ST | ExpreS2ion Biotech Holding AB (publ) | 1.22 SEK | −13.48% | −92.74% | −94.61% |
| SPERM.ST | Spermosens AB (publ) | 0.01 SEK | −6.12% | +64.29% | +24.32% |
| GUARD.ST | Disruptive Pharma AB (publ) | 1.47 SEK | −7.67% | +1.94% | −93.42% |
| PERP-B.ST | Perpetua Medical AB (publ) | 3.04 SEK | −17.84% | −41.54% | −38.34% |
| DBP-B.ST | Double Bond Pharmaceutical International AB (publ) | 0.12 SEK | −4.98% | −7.46% | +3.33% |
| PROGEN.ST | Prostatype Genomics AB (publ) | 0.16 SEK | +4.49% | −57.66% | −77.67% |
| ZENI.ST | Zenicor Medical Systems AB (publ) | 0.95 SEK | −5.00% | −14.41% | −60.42% |
| VSD-B.ST | Vibrosense Dynamics AB (publ) | 0.65 SEK | +1.88% | −31.94% | −60.00% |
| GABA.ST | Gabather AB (publ) | 0.03 SEK | +8.18% | +19.44% | −2.27% |
| PHAL.ST | PharmaLundensis AB | 0.32 SEK | 0.00% | +8.19% | +37.83% |
| POLAR.ST | PolarCool AB (publ) | 1.83 SEK | +15.09% | −53.32% | −67.32% |
| RESP.ST | Respiratorius AB (publ) | 2.47 SEK | +17.62% | +41.95% | −33.60% |
| ATORX.ST | Alligator Bioscience AB (publ) | 0.03 SEK | −25.55% | −91.07% | −99.27% |
| SPEC.ST | SpectraCure AB (publ) | 0.03 SEK | −18.83% | −83.21% | −84.73% |
| IMS.ST | Invent Medic Sweden AB (publ) | 0.10 SEK | +5.32% | −69.82% | −26.67% |
| MONI.ST | Monivent AB | 0.17 SEK | −2.82% | −47.24% | −8.27% |
| APTA.ST | Aptahem AB (publ) | 0.52 SEK | −19.69% | −54.81% | −70.17% |
| NANECH.ST | NanoEcho AB (publ) | 0.03 SEK | −11.76% | −61.78% | −76.92% |
| 2CUREX.ST | 2cureX AB (publ) | 0.49 SEK | −71.68% | −8.92% | −79.92% |
| ODIN.ST | Odinwell AB (publ) | 0.15 SEK | −18.94% | −48.59% | −57.21% |
| MAGLE.ST | Magle Chemoswed Holding AB (publ) | 0.40 SEK | −20.79% | −97.66% | −98.18% |
| ISAB.ST | Inhalation Sciences Sweden AB (publ) | 0.16 SEK | −26.16% | −66.21% | −70.73% |
| LXB.ST | Luxbright AB (publ) | 0.06 SEK | −37.78% | −88.73% | −91.91% |
| S2M.ST | S2Medical AB (publ) | 0.00 SEK | −18.52% | −56.00% | −66.15% |
| NIDHOG.ST | Nidhogg Resources Holding AB (publ) | 0.49 SEK | +10.68% | −39.50% | −73.53% |
| SDET.ST | SensoDetect Aktiebolag (publ) | 0.00 SEK | −27.27% | −97.75% | −99.53% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.